Crescita Therapeutics Inc. (CTX.TO)
CAD 0.57
(1.79%)
CAD 0.57
(1.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 17.52 Million | 23.52 Million | 16.76 Million | 15.64 Million | 22.33 Million | 16.62 Million |
| Cost of Revenue | 7.15 Million | 10.34 Million | 6.75 Million | 4.36 Million | 5.8 Million | 5.53 Million |
| Gross Profit | 10.36 Million | 13.18 Million | 10.01 Million | 11.27 Million | 16.53 Million | 11.08 Million |
| Operating Expenses | 12.32 Million | 12.65 Million | 10.73 Million | 9.71 Million | 11.56 Million | 11.12 Million |
| Selling, General and Administrative Expenses | 10.11 Million | 10.57 Million | 8.72 Million | 7.12 Million | 8.46 Million | 10.06 Million |
| Research and Development Expenses | 699 Thousand | 609 Thousand | 634 Thousand | 1.1 Million | 1.37 Million | 1.06 Million |
| Other Expenses | 1.5 Million | 1.47 Million | 1.37 Million | 1.49 Million | 1.72 Million | 455 Thousand |
| Cost and Expenses | 19.47 Million | 22.99 Million | 17.48 Million | 14.08 Million | 17.36 Million | 16.66 Million |
| Operating Income | -1.95 Million | 732 Thousand | -529 Thousand | 2.51 Million | 3.97 Million | -37 Thousand |
| Interest Expense | 85 Thousand | 158 Thousand | 236 Thousand | 252 Thousand | 679 Thousand | 603 Thousand |
| Income Tax Expense | 456 Thousand | -458 Thousand | 96 Thousand | 483 Thousand | 1.32 Million | -1.77 Million |
| Earnings before Tax | -1.53 Million | 404 Thousand | -1 Million | 520 Thousand | 3.18 Million | 649 Thousand |
| Net Income | -1.98 Million | 862 Thousand | -1.1 Million | 37 Thousand | 1.85 Million | 2.39 Million |
| Earnings Per Share Basic | -0.10 | 0.04 | -0.05 | 0.00 | 0.09 | 0.12 |
| Earnings Per Share Diluted | -0.10 | 0.04 | -0.05 | 0.00 | 0.08 | 0.12 |
| Weighted Average Shares Outstanding | 20.25 Million | 20.69 Million | 20.75 Million | 20.66 Million | 20.94 Million | 19.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 20.25 Million | 21 Million | 20.75 Million | 20.96 Million | 22.49 Million | 19.7 Million |
| Gross Margin | 0.59 | 0.56 | 0.60 | 0.72 | 0.74 | 0.67 |
| EBIT Margin | 0.00 | 0.09 | 0.05 | 0.26 | 0.26 | 0.10 |
| Profit Margin | -0.11 | 0.04 | -0.07 | 0.00 | 0.08 | 0.14 |
| EBITDA | 45 Thousand | 2.09 Million | 598 Thousand | 2.26 Million | 5.58 Million | 2.39 Million |
| Earnings Before Tax Margin | -0.11 | 0.03 | -0.03 | 0.16 | 0.18 | -0.00 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.08 Million | 4.99 Million | 17.52 Million | 4.72 Million | 3.03 Million | 5.16 Million |
| Cost of Revenue | 2.15 Million | 2.97 Million | 8.66 Million | 2.04 Million | 1.53 Million | 2.09 Million |
| Gross Profit | 1.93 Million | 2.02 Million | 8.85 Million | 2.68 Million | 1.49 Million | 3.06 Million |
| Operating Expenses | 2.97 Million | 2.75 Million | 10.81 Million | 2.79 Million | 2.88 Million | 3.29 Million |
| Selling, General and Administrative Expenses | 2.81 Million | 2.58 Million | - | 2.57 Million | 2.36 Million | 2.74 Million |
| Research and Development Expenses | 163 Thousand | 170 Thousand | - | 218 Thousand | 143 Thousand | 178 Thousand |
| Other Expenses | 304 Thousand | - | - | - | - | - |
| Cost and Expenses | 5.13 Million | 5.72 Million | 19.47 Million | 4.83 Million | 4.41 Million | 5.38 Million |
| Operating Income | -1.04 Million | -731 Thousand | -1.95 Million | -113 Thousand | -1.38 Million | -226 Thousand |
| Interest Expense | 17 Thousand | 18 Thousand | 85 Thousand | 20 Thousand | 21 Thousand | 21 Thousand |
| Income Tax Expense | -2000.00 | 9000.00 | 456 Thousand | 197 Thousand | 30 Thousand | 123 Thousand |
| Earnings before Tax | -928 Thousand | -617 Thousand | -1.54 Million | 57 Thousand | -1.28 Million | -188 Thousand |
| Net Income | -926 Thousand | -626 Thousand | -1.98 Million | -150 Thousand | -1.28 Million | -281 Thousand |
| Earnings Per Share Basic | -0.05 | -0.03 | - | -0.01 | -0.06 | -0.01 |
| Earnings Per Share Diluted | -0.05 | -0.03 | - | -0.01 | -0.06 | -0.01 |
| Weighted Average Shares Outstanding | 19.44 Million | 19.59 Million | 20.25 Million | 19.98 Million | 20.36 Million | 20.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.44 Million | 19.59 Million | 20.25 Million | 19.98 Million | 20.36 Million | 20.33 Million |
| Gross Margin | 0.47 | 0.41 | 0.51 | 0.57 | 0.49 | 0.59 |
| EBIT Margin | -0.18 | -0.07 | - | 0.06 | -0.29 | 0.05 |
| Profit Margin | -0.23 | -0.13 | -0.11 | -0.03 | -0.42 | -0.05 |
| EBITDA | -740 Thousand | -346 Thousand | - | 266 Thousand | -882 Thousand | 274 Thousand |
| Earnings Before Tax Margin | -0.26 | -0.15 | -0.11 | -0.02 | -0.46 | -0.04 |
0W19
TATACOMM
BU
AUMTF
IAT
6159